Rekah Pharmaceutical Industry Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 77.65M 29.24B 106M | Sales 2023 | 322M 85.43M 32.17B 117M | Capitalization | 169M 44.8M 16.87B 61.22M |
---|---|---|---|---|---|
Net income 2022 | -2M -531K -200M -726K | Net income 2023 | -6M -1.59M -600M -2.18M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 38.62M 14.54B 52.77M | Net Debt 2023 | 166M 44.2M 16.64B 60.4M | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 93-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 18-10-31 |
Director/Board Member | 78 | 93-08-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-14 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-14 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-14 |
1st Jan change | Capi. | |
---|---|---|
+26.15% | 75.76B | |
-2.46% | 23.95B | |
+14.23% | 8.7B | |
+1.47% | 8.29B | |
-32.92% | 6.7B | |
+18.62% | 5.38B | |
+1.10% | 4.08B | |
-9.24% | 3.79B | |
-10.20% | 3.3B |